Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > TGA approves CBD down scheduling.
View:
Post by Lemoyne on Dec 16, 2020 9:57am

TGA approves CBD down scheduling.

CBD to be available over the counter following product approval by TGA.

Daily dose increased to 150mg/day from 60mg/day.

https://www.tga.gov.au/media-release/over-counter-access-low-dose-cannabidiol
Comment by lscfa on Dec 16, 2020 10:07am
Also, Australia has almost no COVID cases so economy back to normal.
Comment by Lemoyne on Dec 16, 2020 10:33am
Maximum of 4500mg/unit (30 days worth of cbd under TGA decision)... that's 90mls of CBD50... Hopefully, LABS manages to get multiple products approved.
Comment by allibabba on Dec 16, 2020 11:39am
Good news.  It appears valens has launched cbd 100 with emerald health.
Comment by Lemoyne on Dec 16, 2020 12:02pm
Interesting, curious to see what type of measurement tool they use, you have a link?
Comment by allibabba on Dec 16, 2020 12:25pm
https://albertacannabis.org/search?q=Sync&f=in_stock%3Dtrue%7Cfalse not sure if that works.  It's near the bottom of the page.  Sync 100 cbd, 20ml.
Comment by Lemoyne on Dec 16, 2020 12:57pm
I would tend to think they made a mistake. Probably cbd 50. They don't have cbd 100 listed on the emerald health website while they have cbd 50 (which is not on alberta website). Also, it's priced for cbd 50 level. This would be really really cheap for cbd 100/ 2000mg of cbd if you compare it to their other cbd price points. If it is cbd 100, there are no margins there.
Comment by allibabba on Dec 16, 2020 1:06pm
I agree but unfortunately I see much more margin compression in the sector with the amount of players currently in the game.  Small margins are better than no sales!  
Comment by Lemoyne on Dec 16, 2020 1:10pm
By no margins there, i'm saying they are selling at a loss.
Comment by allibabba on Dec 16, 2020 1:38pm
I'm not sure about that.  Depends on the efficiency and scale of the process I suppose.  
Comment by Lemoyne on Dec 16, 2020 2:02pm
Ok, just to put emerald 100 cbd (20ml) in perspective. Cortalex sells 100 cbd on shoppers but in 30ml quantities so 3000mg vs 2000mg for emerald (1.5x). So Cortalex sells 1.5x amount of cbd for 400$. https://cannabis.shoppersdrugmart.ca/en_CA/products/Cortalex-Cardiol-Therapeutics-Cortalex-100-CBD-Oil-Hybrid/222 Emerald: 90 bucks for 2000mg =135 for 3000mg, so you're looking at almost 70 ...more  
Comment by allibabba on Dec 16, 2020 2:37pm
Could very well be a mistake.  
Comment by allibabba on Dec 16, 2020 2:41pm
I did say to friends more than a year and a half ago that mergers were going to happen and companies too stubborn to bite their pride and make a deal were going to get left for the vultures.  I am very interested in the aphria/tilray deal.  I think you will see a similar deal with canopy growth in the near future.  Cronos also has to make a deal VERY soon or the are toast.  I ...more  
Comment by allibabba on Dec 16, 2020 2:45pm
There is only room for 2 maybe 3 giants and we now have 1.  Tic toc tic toc 
Comment by Lemoyne on Dec 16, 2020 6:38pm
No doubt time is running out, but not merger wise, more like if they don't manage to make significant intl sales increase in Q1, they will be seriously punished. Especially if they do not ship stada material in Q1.
Comment by Righttothetop on Dec 17, 2020 7:14am
LABS cannot be punished any further than it has given what the financials are.  They can't ship Stada goods without EUGMP, which is wholly contingent on whether the German regulator comes across to validate....which, given the COVID circumstances, seems like a stretch and is completely outside the control of the business.  Had COVID not happened, EUGMP would have been achieved months ...more  
Comment by Lemoyne on Dec 17, 2020 8:24am
From what I understand, LABS can ship to EU through Aussie subsidiairy. The bottleneck is product registration/ licensing approval. Once they obtain those licenses from german BfarM for their stada products, they'll be able to ship. Same for all the other intl markets (peru, brazil, denmark, UK, NZ).
Comment by Lemoyne on Dec 17, 2020 9:32am
They announced cbd 100 today! Damn, unless they have made a mistake in pricing that is soooooo cheap! I suppose they do have some margins?!?!
Comment by allibabba on Dec 17, 2020 11:19am
Everything is this sector is wayyyyy overpriced.  Explain to be why cbd pills should be any more expensive than Advil liquigels or Jamieson fish oil capsules.  The answer is it shouldn't.  As more companies come onboard and the oil glut continues, price compression will continue.  Still had a long way to go in my opinion.
Comment by allibabba on Dec 17, 2020 11:27am
If this was a life saving drug that only a few companies were setup to do i could understand, however pot and hemp grow like any other crop and is very cheap to produce especially outdoors. There are hundred and hundreds of companies in the sector and lots of companies doing extraction.
Comment by Lemoyne on Dec 17, 2020 11:55am
Sorta get what you say, but cbd isn't the same as advil. It is more regulated, you need a sh*t ton of licenses to produce this. Also, it doesn't only reduce pain, it has additional functions for which it can be prescribed. I don't see any clinical trials about advil treatment for chronic diseases. Comparing to advil or fish oil is a bit extreme. You are contradicting your M&A ...more  
Comment by allibabba on Dec 17, 2020 12:13pm
I am not trying to be argumentative here but are you seriously trying to tell me that Advil which hundreds of millions of people take daily is not as regulated as cbd capsules?  I can't say that I know the real answer to that but I find it hard to believe.
Comment by Righttothetop on Dec 17, 2020 12:33pm
Fladdi....how many people have an alcoholic beverage each day......how regulated is that drug? Regulations don't always make sense, and they certainly do not apply strictly on volume.....CBD is a damn near untested compound when compared to Advil...so ya, it's more 'regulated' (aka controlled) than CBD.  That will change as our friends Down Unda have proven.
Comment by allibabba on Dec 17, 2020 12:46pm
I'll agree with you on that on right.  However I believe alcohol is treated as food and not a controlled drug.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities